Taglutimide
Taglutimide (Biglumide; K 2004) is an orally active hypnotic agent. Taglutimide lowers plasma levels of diphenhydramine in rats and shortens the duration of anesthesia. Taglutimide is used in research on neurological disorders such as sedation and hypnosis.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 14166-26-8
- Formule: C14H16N2O4
- Masse moléculaire:276.29
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Chemical Information
-
CAS No. 14166-26-8
-
Masse moléculaire 276.29
-
Formule C14H16N2O4
-
SMILES
O=C1NC(C(CC1)N2C(C3C(C4CCC3C4)C2=O)=O)=O
-
Synonyms
Biglumide; K 2004
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Jurecka W, et al. Teratologisch-neurotoxische Prüfung von Biglumid (K-2004) und Thalidomid [Teratologic-neurotoxicologic studies on biglumide (K-2004) and thalidomide]. Arch Toxicol. 1977 Jun 18;37(2):165-72. German. [Content Brief]
[2]. Wiener H, et al. Induction of drug metabolism in the rat by taglutimide, a sedative-hypnotic glutarimide derivative. Eur J Drug Metab Pharmacokinet. 1980;5(2):93-7. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)